Welcome to our dedicated page for Parkervision news (Ticker: PRKR), a resource for investors and traders seeking the latest updates and insights on Parkervision stock.
ParkerVision, Inc. (PRKR) is a Florida-based RF technology company whose news flow is heavily shaped by intellectual property, litigation, and capital markets developments. The company describes itself as an innovator in radio-frequency (RF) technologies used in advanced wireless communication systems and as a developer and marketer of technologies and products for wireless applications. Its press releases frequently highlight how these RF technologies are protected and monetized through licensing and patent enforcement.
A major theme in ParkerVision’s news is its long-running patent litigation, particularly against Qualcomm. The company issues detailed updates on claim construction rulings, appeals to the U.S. Court of Appeals for the Federal Circuit, motions such as Rule 54(b) requests and motions to expedite, and scheduling developments in its cases. Additional coverage focuses on patent infringement actions in the Western District of Texas involving Realtek, MediaTek, Texas Instruments, and NXP Semiconductors, as well as related Patent Trial and Appeal Board (PTAB) inter partes review proceedings.
Investors following PRKR news will also see regular earnings releases and financial updates, where ParkerVision reports net losses, operating expenses, contingent payment obligations, and cash flows. The company explains how changes in the estimated fair value of contingent payment obligations and share-based compensation affect its results, and it comments on legal and consulting costs tied to its enforcement activities.
Another recurring news category involves capital-raising activity. ParkerVision has announced a shelf registration on Form S-3 and subsequent registered direct offerings of common stock under that shelf, including sales to accredited and institutional investors and to a director. These announcements outline offering terms, use of the shelf registration, and the absence of underwriters or placement agents.
For readers tracking PRKR, this news page provides a centralized view of ParkerVision’s litigation milestones, financial disclosures, and financing transactions, all of which the company presents as central to its RF intellectual property strategy.
ParkerVision (OTCQB:PRKR) completed appellate briefing on April 4, 2026, appealing the Orlando district court's claim construction that led to a non-infringement stipulation and judgment.
ParkerVision says Qualcomm's Federal Circuit brief contains a contradiction that undermines the prior issue-preclusion basis; ParkerVision asks the Federal Circuit to reverse and remand for trial.
ParkerVision (OTCQB:PRKR) reported year ended December 31, 2025 results, posting a net loss of $7.4M ($0.06/sh) versus a $14.5M loss in 2024 ($0.16/sh). Cash was $4.4M with ~$2.3M working capital. Key legal developments include an expedited CAFC appeal schedule in ParkerVision v. Qualcomm and a postponed MediaTek trial pending updated expert reports.
The company recognized a $0.6M fair-value gain on contingent payment obligations in 2025 versus a $9.6M loss in 2024 and completed a registered direct offering raising ~$4.5M in November 2025.
ParkerVision (OTCQB:PRKR) announced the jury trial in its patent infringement action against MediaTek, originally set for March 20, 2026 in Waco, Texas, has been postponed.
Judge Albright reviewed a Daubert motion on March 16, 2026; the Court took the trial off calendar pending updated expert reports and briefing, and will issue a revised pretrial and trial schedule after submissions.
ParkerVision (OTCQB:PRKR) said the jury trial in its patent infringement action against MediaTek will commence on March 20, 2026 in Waco, Texas, with jury selection the preceding day.
The trial had been scheduled to start March 23, 2026; the district court changed the start date at its request. The company noted its ongoing patent licensing and enforcement efforts and provided investor contacts.
ParkerVision (OTCQB: PRKR) filed its opening brief in its expedited appeal to the Court of Appeals for the Federal Circuit in ParkerVision v. Qualcomm and said the CAFC reinstated an expedited briefing schedule on January 21, 2026.
The schedule set ParkerVision's opening brief due Feb 4, 2026, Qualcomm's response due Mar 16, 2026, and ParkerVision's final reply seven days later; oral argument will follow briefing. The company also requested reassignment and noted two upcoming trials: MediaTek on Mar 23, 2026, and a combined Realtek trial on Apr 27, 2026.
ParkerVision (OTCQB:PRKR) closed a registered direct offering on November 24, 2025, selling 16,481,579 shares of common stock at $0.21 per share for gross proceeds of approximately $3.46 million.
The sale was completed under a Shelf registration declared effective by the SEC on May 28, 2025. Including a $1.0 million common stock purchase by a director on November 17, 2025, the company has raised an aggregate of about $4.46 million under the Shelf.
ParkerVision (OTCQB:PRKR) closed a registered direct offering on November 17, 2025, selling 4,761,905 shares of common stock to independent director Lewis H. Titterton, Jr. at $0.21 per share for gross proceeds of $1,000,000.
The per-share price matched the last reported sale price on November 14, 2025. The shares were issued under the Company’s shelf registration filed April 2025 and declared effective by the SEC on May 28, 2025; this is the first transaction completed under that Shelf.
The company describes its business as developing and licensing RF technologies and notes ongoing U.S. patent enforcement actions. Contact information for CFO Cindy French and Communications Director Tony Vignieri is provided.
ParkerVision (OTCQB:PRKR) reported results for the three and nine months ended September 30, 2025. Q3 net loss was $2.0M ($0.02/share) versus $10.8M ($0.12/share) in Q3 2024; YTD net loss was $7.4M ($0.06/share) versus $11.8M ($0.13/share) prior year. Cash and cash equivalents totaled $0.9M at September 30, 2025. Changes in the fair value of contingent payment obligations and increased share-based compensation materially influenced results. Multiple patent trials and an expedited CAFC appeal schedule are pending in 2026.
ParkerVision (OTCQB:PRKR) announced that the U.S. Court of Appeals for the Federal Circuit granted its October 13, 2025 motion to expedite the appeal in ParkerVision v. Qualcomm (Case No. 2026-1033).
The court set a briefing schedule: opening brief due December 1, 2025, Qualcomm response due January 16, 2026, ParkerVision reply due February 6, 2026, and oral argument scheduled for the next available session after briefing completes.
ParkerVision said the appeal challenges a May 2025 district court claim construction that added a "generating limitation" and led to stipulated summary judgment of non-infringement of its receiver patent claims.
ParkerVision (OTCQB:PRKR) filed a motion with the U.S. Court of Appeals for the Federal Circuit to expedite its patent-infringement appeal against Qualcomm after a May 2025 claim construction and summary judgment of non-infringement. The company asked the court to shorten the briefing schedule, proposing opening briefs by December 1, 2025 and oral argument in March 2026, citing more than 11 years of pending litigation and risk of lost evidence and witness availability.
The motion argues the district court added a "generating limitation" contrary to the patents' plain language and prior Federal Circuit guidance and seeks accelerated resolution to avoid further prejudice to ParkerVision's ability to present the factual record.